The week in health tech, explained in plain English.Get the free newsletter →
October 4, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Payers

AI Finally Changes the Math on Healthcare Fraud

Healthcare fraud, waste, and abuse drains more than $100 billion from the U.S. system every year, and by some estimates several times that, according to HIT Consultant. That number has been stubbornly familiar for decades. What has changed is the detection technology. AI can now scan claims, billing patterns, and provider behavior at a scale and speed that legacy rules-based systems never could, flagging anomalies that human auditors would miss.

The practical shift is from reactive to proactive. Older methods chased fraud after payment through a slow "pay and chase" cycle. Modern AI models can spot suspicious patterns before dollars go out the door, tightening the window that bad actors exploit. That reframes the economics: the cost of catching fraud is falling as the tools mature.

The open question, HIT Consultant argues, is adoption. The technology works. Whether payers, providers, and regulators will invest in it and act on its findings, rather than tolerate losses as a cost of doing business, is now the deciding factor.

More in Payers

Payers

7 Health System Insurers to Exit Medicare Advantage in 2027

Seven health system-owned insurers are among 11 health plans exiting the individual Medicare Advantage market in 2027, with several others narrowing to special needs plans only.

Why it matters: The exits signal that even provider-owned plans are struggling with Medicare Advantage economics, forcing seniors to find new coverage.

Payers

CMS Projects Lower MA Premiums, Flat Enrollment for 2027

CMS projects lower average Medicare Advantage premiums and flat enrollment of 34 million for 2027, a figure that already trails current membership of 36.1 million.

Why it matters: Medicare Advantage now covers nearly half of all Medicare enrollees, so its premium and growth trajectory shapes revenue for insurers, providers, and the federal budget.

Payers

PBMs Become Rare Bipartisan Target in Washington and States

A bipartisan push in Congress and statehouses aims to rein in pharmacy benefit managers, including proposals to force CVS and rivals to split their PBM and pharmacy businesses.

Why it matters: PBMs sit at the center of US drug pricing, and forced divestiture would upend the business models of the largest healthcare conglomerates.